Press Release

Alkemia SGR rafforza la propria presenza in IDNTT salendo al 17% del capitale sociale dopo l'acquisto di 533.000 azioni. Nell'attuale assetto azionario figura anche Pharus SICAV, che detiene una partecipazione del 5,3%...

According to an analysis by Advisor, the biotech sector continues to offer positive long-term prospects, supported by innovation, artificial intelligence, new drug development, and M&A activity.

The Magnificent Seven lost approximately .3 trillion in market capitalization during June, reigniting concerns about a potential artificial intelligence bubble.

Pharus’ investment team highlights the paradox of the past week in the markets: the tech sell-off came precisely after geopolitical tensions eased, triggered by fears of a slowdown in the AI cycle following signals from South Korea...

IDNTT has successfully completed its accelerated bookbuilding process, placing all of the newly issued shares and attracting strong demand from institutional investors.

In the second half of 2026, equity fund selection requires a more rigorous approach, against a backdrop of increased volatility, greater dispersion across sectors, and geopolitical uncertainty.

The article analyzes Kevin Warsh’s debut as Chair of the Federal Reserve. The Fed left interest rates unchanged but adopted an extremely concise communication style, removing any guidance on future monetary policy moves.

If the ceasefire in the Middle East were to become more firmly established, the bond market could benefit from a decline in yields, particularly at the short end of the curve (12–36 months), which has been most affected by the rise in oil prices.